In the biopharmaceutical
industry, optimizing bioreactor cellular health and titer quality requires accounting for micronutrients as well as contaminants; too little or too much can have a negative impact. Without meticulous control of raw materials and media components, a small deviation in micronutrients can lead to an out-of-specification (OOS) event, low titer quality, and a slow-down or halt of drug production. Quality aspects to support all biopharmaceutical product lines concerning optimizing micronutrients
and controlling contaminants can be complex, but Brooks Applied Labs is here to help. Watch this fun and informative video to learn more!